Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2

Conditions

Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, B-Cell 2Neoplasms 1Multiple Myeloma 1Leukemia 1

Interventions

Cyclophosphamide 23fludarabine 15fludarabine phosphate 10Methotrexate 10Whole-Body Irradiation 9blinatumomab 8Vincristine 7Specimen Handling 7Dexamethasone 7merphos 6Tacrolimus 6Mycophenolic Acid 6Stem Cell Transplantation 5Peripheral Blood Stem Cell Transplantation 5Mesna 5Mercaptopurine 5Melphalan 5Leukapheresis 5Granulocyte Colony-Stimulating Factor 5Filgrastim 5Cytarabine 5Cyclosporine 5Biopsy 5pegaspargase 4Prednisone 4Magnetic Resonance Spectroscopy 4Etoposide 4Calcium Dobesilate 4Busulfan 4prednylidene 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Immunotherapy, Adoptive × 30 days × Clear all
NCT03186118 2026-06-05

Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia

Seattle Children's Hospital

Phase 1 Active not recruiting
30 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03919240 2026-06-04

CAR-T Cell Therapy Targeting to CD19 for R/R ALL

The First Affiliated Hospital of Soochow University

Phase 1/2 Active not recruiting
196 enrolled
LymphoidOther hematologic neoplasm

Recurrence, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡